Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o.
- Address
- Ul. Henryka Michala Kamienskiego 73a, 51-124 Wroclaw, Poland
Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet
The Dolnoslaskie Centrum Chorob Serca (Lower Silesian Heart Disease Center), named after Professor Zbigniew Religa, is a specialized cardiovascular research facility in Poland dedicated to advancing the understanding and treatment of heart failure. The center participates in innovative Phase 2 clinical trials investigating novel therapeutic approaches for patients with various forms of chronic heart failure.
- Heart failure with reduced ejection fraction (HFrEF) therapeutic development
- Heart failure with preserved ejection fraction (HFpEF) treatment strategies
- Assessment of biomarkers including NT-proBNP in heart failure management
The center's research portfolio focuses on dose-finding and efficacy studies of tovinontrine, an investigational agent for heart failure management. Their expertise encompasses comprehensive evaluation of safety profiles and therapeutic effectiveness in different heart failure phenotypes, contributing to the development of precision medicine approaches for cardiovascular patients. The facility's commitment to studying both HFrEF and HFpEF demonstrates their comprehensive approach to addressing the full spectrum of heart failure conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Agencja Badań Medycznych1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Cardurion Pharmaceuticals Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Low-Dose Acetylsalicylic Acid Plus Prasugrel Versus Low- and High-Dose Acetylsalicylic Acid on Graft Patency in Stable Coronary Artery Disease Post-CABG | Agencja Badań Medycznych, Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o. | Phase III | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tovinontrine | 2 | Unknown | 2024-08-08 | 2024-08-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.